K Morgan, I Oswald. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Anti-Anxiety Agents/adverse effectsAnti-Anxiety Agents/therapeutic useAnxiety Disorders/chemically inducedBenzodiazepinesBenzodiazepinones/therapeutic useClinical Trials as TopicDouble-Blind MethodFemaleHalf-LifeHumansMaleMiddle AgedSubstance Withdrawal SyndromeTriazolam/adverse effectsTriazolam/metabolismTriazolam/therapeutic use
Substances: See more » Anti-Anxiety AgentsBenzodiazepinonesBenzodiazepinesTriazolamtriazulenone
Year: 1982 PMID: 6121606 PMCID: PMC1496517 DOI: 10.1136/bmj.284.6320.942
Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN: 0267-0623